ArticleOncotarget2016

Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia.

Kamilla M E Laidlaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.